Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q4 FY20 results · Jan–Mar 2020
Dr. Lal Path Labs reported revenue from operations of ₹301.70 crore (up 0.2% from Q4 FY19) and net profit of ₹32.60 crore (down 31.2% from Q4 FY19) for Q4 FY20 (Jan–Mar 2020), on a consolidated basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 301.70 | 301.10 | +0.2% | 327.90 | −8.0% |
| Other income | 12.00 | 13.50 | −11.1% | 13.80 | −13.0% |
| Total income | 313.70 | 314.60 | −0.3% | 341.70 | −8.2% |
| Profit before tax | 45.40 | 69.20 | −34.4% | 73.40 | −38.1% |
| Net profit for the period | 32.60 | 47.40 | −31.2% | 54.90 | −40.6% |
| Attributable to shareholders of the company | 32.50 | 47.10 | −31.0% | 54.10 | −39.9% |
| EPS, basic (₹) | 3.94 | 5.72 | −31.1% | 6.56 | −39.9% |
| Net margin (%) | 10.8 | 15.7 | 16.7 |
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 287.50 | 292.00 | −1.5% | 310.40 | −7.4% |
| Other income | 14.00 | 13.00 | +7.7% | 13.30 | +5.3% |
| Total income | 301.50 | 305.00 | −1.1% | 323.70 | −6.9% |
| Profit before tax | 47.60 | 67.10 | −29.1% | 68.60 | −30.6% |
| Net profit for the period | 35.30 | 46.00 | −23.3% | 51.10 | −30.9% |
| EPS, basic (₹) | 4.28 | 5.59 | −23.4% | 6.20 | −31.0% |
| Net margin (%) | 12.3 | 15.8 | 16.5 |
Consolidated
- Filed with BSE
- 18 May 2020, 18:46 IST
- Board meeting
- 18 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 18 May 2020, 18:46 IST
- Board meeting
- 18 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE